ARS Investment Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
Other funds holding CEMI
SBH
RA
PM
PCM
IC
ARS Investment Partners's CEMI Position: Q1 2021 in Review
ARS Investment Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2021, closing a stake of 32,400 shares — an estimated $154K sold.
ARS Investment Partners first reported a position in CEMI in Q4 2016 and held it in 16 quarters. The position peaked at $9.21M in Q3 2018. 72 funds tracked by Wall St. Rank hold CEMI as of Q1 2021.
- ARS Investment Partners reported no remaining Chembio diagnostics, Inc. position as of Q1 2021 after selling out during the quarter.
- ARS Investment Partners sold 32,400 Chembio diagnostics, Inc. shares in Q1 2021, an estimated $154K.
- ARS Investment Partners first reported a position in Chembio diagnostics, Inc. in Q4 2016 and held it in 16 quarters.
- ARS Investment Partners's Chembio diagnostics, Inc. position peaked at $9.21M in Q3 2018.
- 72 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2021.
Based on ARS Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.